Human Genome Sciences, Inc. (HGSI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeffrey Ogbar who wrote ()	2/2/1998 9:11:00 AM
From: Henry Niman	Read Replies (1) of 1127

HGSI was mentioned on CNBC this morning because of its large deal with SBH as well as the emphasis on genomics and associated costs of developing drugs (as one of the drivers of the GLX/SBH merger. I have linked the CNBC coverage to the Biotech impact area of the GLX/SBH merger section at home.att.net

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next